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Diabetes 
1. INTRODUCTION 
The hepatic binding 
Hepatic lectin Asialoglycoprotein Isolated hepatocyte 
protein, a mammalian 
membrane lectin [l], recognizes the serum galac- 
tose-terminated desialylated glycoproteins and me- 
diates their uptake and lysosomal degradation 
(2,3]. The decrease of its biological activity has 
been reported [4] in streptozotocin-diabetic rat 
hepatocytes. A dirct correlation has been estab- 
lished between this decrease and the lowering of 
hepatic lectin content on the surface of diabetic rat 
hepatocytes [5]. 
able to show that the hepatic lectin, present on dia- 
betic hepatocyte membranes, is normally sialyl- 
ated. So, in diabetes mellitus, the decrease of the 
hepatic lectin activity is not directly related to the 
lowering of the sialic acid content of hepatocyte 
surface glycoproteins. 
2. MATERIALS AND METHODS 
Stockert et al. have shown that the removal of 
sialic acid from this purified membrane lectin vir- 
tually abolishes its capacity to bind galactose-ter- 
minated disialylated glycoproteins such as asi- 
aloorosomucoid [6]. Since a decrease of the sialic 
acid content of the hepatic membrane in the dia- 
betic state has been shown by several authors 
[7,10], this data could explain our previous results. 
Whereas the purified desialylated hepatic lectin 
does not recognize asialoorosomucoid, the de- 
sialylated ovine submaxillary mucin, a glycopro- 
tein whose carbohydrate moiety consists almost 
entirely of N-acetylgalactosaminyl residues is re- 
cognized by the both sialylated and desialylated 
hepatic lectin [6,11]. 
Human orosomucoid and desialylated ovine 
submaxillary mucin were kindly supplied by Pro- 
fesseur Montreuil (UniversitC des Sciences et 
Techniques, Lilles, France) and Professeur Van 
den Eijnden (Vrije Universiteit, Amsterdam, The 
Netherlands) respectively. Asialoglycoproteins 
were labelled as described previously 141. Their 
specific activities were about 0.7 X 106 dpm/pg. 
Collagenase was obtained from Worthington. 
Male Sprague-Dawley rats (275-300 g) were ob- 
tained from Charles Rivers (France). Scintillation 
fluid (aqueous combining system) was from 
Amersham (France). Other chemicals were reagent 
grade. 
2.1. Rat treatment and cell preparation 
By exploiting this difference in affinity of the 
hepatic lectin, for galactosyl and N-acetylgalac- 
tosaminyl-terminating glycoproteins, we have been 
Abbreviations: ASOR, asialoorosomucoid; DOSM, de- 
sialylated ovin submaxillary mucin. 
After an overnight fast (with free access to 
water) rats were randomly divided into two 
groups. Animals from one group received strep- 
tozotocin (65 mg/kg body weight, dissolved in iso- 
tonic saline acidified to pH 4.5 with citric acid) 
through the tail vein (diabetic rats). Rats from con- 
trol group were injected with the medium alone 
(normal rats). After 11 days, animals with a blood 
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sugar level superior to 250 mg/ 100 ml were consid- 
ered as diabetic and used for cell preparation. 
Hepatocytes were prepared using the collagenase 
perfusion procedure of Berry and Friend [12]. 
Final cell pellets were suspended in Krebs buffer 
containing 0.15 M NaCl, 0.005 M KCl, 0.001 M 
KHzP04, 0.001 M MgS04, 0.003 M CaClz, 0.025 
M NaHCO3, maintained at pH 7.4 with con- 
tinuous gassing of 02/CO2 (95/5). Routinely 70- 
85% of single cells and 80-90% of viable cells, as 
judged by either trypan blue exclusion or the re- 
lease of lactate dehydrogenase (EC 11.1.28) [ 131 
were obtained from normal or diabetic rats. 
2.2. Neuraminidase treatment of hepatocytes 
The hepatocytes (1 X lo7 cells/ml), isolated 
from normal rats were incubated in Krebs buffer 
with 100 mu/ml of neuraminidase Vibrio cholerae 
(EC 3.2.1.18, Berhingwerke) for 60 min at 4°C. 
Following incubation, cells were centrifuged 50 x 
g for 2 min and washed with 10 volumes of ice- 
cold Krebs buffer. No modification of cell-viability 
was observed during the experiment. 
2.3. Cell-surface binding 
To measure the surface binding capacity, 
hepatocytes (1 x lo6 cells/ml) were suspended in 
Krebs buffer and incubated for 60 min at 4°C with 
4 pg/ml of radiolabelled ASOR or DOSM. As pre- 
viously reported, this asialoglycoprotein con- 
centration is sufficient to obtain a full saturation of 
surface receptors [4]. The reaction was stopped by 
adding 3 ml of ice-cold Krebs buffer into the 
tubes. Cells were centrifuged 50 x g for 2 min and 
washed four times in ice-cold Krebs buffer. The 
cell pellets were dissolved in 10 ml of scintillation 
fluid and counted in a liquid scintillation spec- 
trometer (Intertechnique SL 30). 
Correction for non-specific binding was made 
by deducing cell associated radioactivity in the ab- 
sence of calcium, which is a requirement for speci- 
tic binding to receptor [ 14,151. 
2.4. Total uptake determination 
For determination of total uptake of ASOR or 
DOSM, hepatocytes (1 x lo6 cell/ml) were incu- 
bated in Krebs buffer containing 4 pg/ml or radio- 
labelled asialoglycoproteins at 37°C for dif- 
ferent times. The cells were kept in suspension in a 
gyratory shaking bath. Then the reaction was 
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stopped and the cells were washed as described 
above. 
3. RESULTS AND DISCUSSION 
Neuraminidase treatment of normal rat 
hepatocytes reduced their capacity to bind and 
take up ASOR by over 80% and 75% respectively, 
without affecting DOSM binding and endocytosis 
(table 1, fig.1). These results agree with those re- 
ported by Stockert et al. [ 111. 
As previously reported [4], the binding and the 
uptake of ASOR by diabetic rat hepatocytes were 
reduced by half as compared to that of normal rat 
hepatocytes (table 1, fig.1). We failed to find any 
discrepancy between the binding and uptake of 
both DOSM and ASOR in diabetic rat hepatocytes 
(table 1, tig.1). 
Since the neuraminidase treatment of 
hepatocytes prevents the interaction of hepatic lec- 
tin with ASOR but not with DOSM, our results 
suggest that the decrease of sialic acid content of 
the hepatic membrane does not account for the 
changes of hepatic lectin behaviour in the diabetic 
state. The desialylated hepatic lectin does not oc- 
cur on the cell surface of diabetic rat hepatocytes. 
We have previously reported [4] that the insulin 
treatment of diabetic rats restores the biological 
properties of hepatic lectin whereas the withdrawal 
of insulin-treatment induces again a loss of its ac- 
tivity. The regulatory mechanism of insulin on 
protein synthesis [16] could account for the de- 
creased content of physiologically active hepatic 
lectin on diabetic hepatocyte membranes. Another 
explanation could be modification of the mem- 
brane fluidity observed in streptozotocin-diabetic 
rat hepatocytes. Indeed Nassar et al. [9] have re- 
cently reported a significant decrease of the 
amount of cholesterol and sialic acid, with no ap- 
preciable change in the phospholipid content, re- 
sulting in a decrease in the cholesterol-phos- 
pholipid ratio. Such membrane changes could 
induce either a defect of the hepatic lectin inser- 
tion into the membrane during its turnover or any 
disruption of the recycling mechanism [16] per- 
mitting a reutilization of the hepatic lectin. In the 
latter case, the amount of intracellular hepatic lec- 
tin [ 171 would not be modified and the effect of in- 
sulin treatment of diabetic rats would induce the 
return to normal membrane fluidity. 
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Table 1 
Surface binding of asialoglycoproteins by isolated rat hepatocytes 
August 1982 
Surface bound asialoglycoproteins (ng/ 106 cells) 
Asialoorosomucoid Desialylated ovin 
submaxillary mucin 
Normal rat hepatocytes 
Neuraminidase-treated 
normal rat hepatocytes 
Diabetic rat hepatocytes 
9.8? 1.5 9+1 
2 kO.5 8+1 
4.2 + 0.6 4 f 0.8 
Each value give the mean 2 SE from six separate experiments using six rats 
of each group. All determinations were performed in triplicate. 
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Fig.1. (A) Kinetic of asialoglycoprotein total uptake by isolated rat hepatocytes. (O-O) ASOR total uptake by un- 
treated hepatocytes; (m-m) DOSM uptake by untreated hepatocytes; (O-O) ASOR total uptake by neuraminidase- 
treated rat hepatocytes; (n-n) DOSM total uptake by neuraminidase-treated rat hepatocytes. (B) Kinetic of total up- 
take of ASOR (O-O) and DOSM ( c-m) by diabetic rat hepatocytes. 
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Whatever the hypothesis retained the injury of 
the hepatic lectin activity in streptozotocin diabetic 
rat hepatocytes can justify the glycoprotein ac- 
cumulation observed by several authors in the dia- 
betic rat serum [ 181. 
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